Clinical Trial

Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements

Name: Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements — clinical trial record (NCT07630584)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a double-blind, randomized, placebo-controlled nutritional study aimed at investigating growth, tolerance, and functional biomarkers in healthy infants receiving dietary supplements from birth to 2.5 months of age

Trial Details

NCT Number	NCT07630584
Lead Sponsor	Société des Produits Nestlé (SPN) Collaborators: University of the East Ramon Magsaysay Memorial Medical Center, Inc, Philippines, Asian Hospital and Medical Center, Muntinlupa, Philippines
Conditions	Healthy Infants
Enrollment	327 participants
Start Date	2026-06-01
Primary Completion	2027-01-31 (estimated)
Study Completion	2028-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-05